Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0000897069-25-000789

Chief Development Officer gave up 3,311 shares (to pay taxes)

  • Chief Development Officer acquired 15,059 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bigora Sian · Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-01 Exercise or conversion : show line 1 in the form +15,059 36,937 D
2025-04-01 Shares withheld for taxes : show line 2 in the form −3,311 $0.41 $1,364 33,626 D
Loading xslF345X05/form4.xml…